Clinical Trial Record

Return to Clinical Trials

Advanced Endoscopy During COVID-19


2020-05-18


2020-07-01


2020-07-05


670

Study Overview

Advanced Endoscopy During COVID-19

In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.

In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details. evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit. Target audience: - Physicians performing advanced gastrointestinal endoscopies in different countries. Objectives: * Primary objective: 1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details. * Secondary objectives: 1. Effect of COVID-19 precautions on procedure time, procedure success, complications and patient outcomes 2. Effect of COVID-19 on working time and staff number Process: A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.

  • Cholangitis, Secondary Biliary
  • Cholangiocarcinoma
  • Obstructive Jaundice
  • Pancreas Cancer
  • COVID-19
  • SARS-CoV-2
  • OTHER: Endoscopic management according to standard of care
  • Global-Endo-COVID

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2020-05-11  

N/A  

2020-07-07  

2020-05-11  

N/A  

2020-07-08  

2020-05-12  

N/A  

2020-07  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: ERCP

Patients who will have endoscopic retrograde cholangiopancreatography

OTHER: Endoscopic management according to standard of care

  • Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case
: EUS

Patients who will have endoscopic ultrasound

OTHER: Endoscopic management according to standard of care

  • Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case
Primary Outcome MeasuresMeasure DescriptionTime Frame
Age, gender, nationalityInvestigators will report the baseline demographic data (age, gender, nationality) of all patients.3 months
Indication for procedure, status of SARS-CoV-2 infectionInvestigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.3 months
Complete blood count and liver functions testsInvestigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.3 months
procedure related complicationsInvestigators will report the procedure related complications.3 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Effect of COVID-19 precautions on procedure timeInvestigators will report wether the precautions lead to increase timing of the procedure3 months
Effect of COVID-19 precautions on staff numberInvestigators will report wether the precautions affected staff number (increased or decreased)3 months

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patients referred for ERCP or EUS during the study period

  • Exclusion Criteria:

  • Patients refusing to participate in the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Helwan University
  • National Liver Institute, Egypt

  • : ,

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available